Sanofi | SAN - Nettoeinkommen





Nettoeinkommen Veränderung Datum
AbbVie USD 3.61B 2.92B 2026-06
Aena EUR 672.53M 343.11M 2026-06
Alcon AG USD 189M 28M 2026-03
Almirall EUR 19.58M 7M 2025-12
Amarin USD -1.22M 6.51M 2025-12
Amgen USD 2.38B 556M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Bayer EUR 219M 2.54B 2026-06
Biogen USD 97.5M 222M 2026-06
BMW EUR 1.62B 149M 2026-03
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Essilor EUR 1.57B 638M 2026-06
Fresenius EUR 382M 53M 2026-06
Fresenius Medical Care EUR 218.38M 100.38M 2026-06
Genmab DKK 303M 250M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
GRIFOLS EUR 154M 81M 2026-06
Hikma Pharmaceutical USD 164M 45M 2025-12
J&J USD 5.53B 299M 2026-06
Lakefront Biotherapeutics EUR 2.11M 12.38M 2026-06
Lonza CHF 426M 119M 2025-06
Mercedes-Benz AG EUR 1.07B 353M 2026-06
Merck EUR 490M 169M 2026-06
Merck USD -1.34B 2.9B 2026-06
Novartis USD 3.26B 108M 2026-06
Novo Nordisk DKK 20.99B 5.9B 2026-06
Orion EUR 140.2M 49.8M 2026-06
Pfizer USD -248M 2.94B 2026-06
Philips EUR 384M 233M 2026-06
Recordati EUR 116.61M 36.45M 2026-06
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 343M 1.27B 2026-06
Sanofi EUR 1.61B 2.42B 2026-03
SAP EUR 2.21B 277M 2026-06
UCB EUR 1.08B 608M 2025-12
Vinci EUR 2.08B 929M 2026-06
Volkswagen EUR 1.29B 1.86B 2026-03